ffa2r antagonist catpb s (Tocris)
Tocris is a verified supplier 
Tocris manufactures this product 
94
Structured Review
Tocris
ffa2r antagonist catpb s
Ffa2r Antagonist Catpb S, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ffa2r+antagonist+catpb+s/CATPB/pm40683327-64-7-16
Average 94 stars, based on 18 article reviews
Ffa2r Antagonist Catpb S, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ffa2r+antagonist+catpb+s/CATPB/pm40683327-64-7-16
Average 94 stars, based on 18 article reviews
ffa2r antagonist catpb s - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
Incubation:Article Title: The ketone body acetoacetate activates human neutrophils through FFA2R Article Snippet: The Article Title: Disruption of the actin cytoskeleton with latrunculin A controls ATP-induced NADPH oxidase activity and the recruitment of G proteins by neutrophil Gα q -coupled receptors. Article Snippet: The P2Y2R antagonist AR-C118925 ((5-[[5-(2,8-dimethyl-5Hdibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]N-2H-tetrazol-5-yl-2-furan-carboxamide)) and the Article Title: THE ACTIN CYTOSKELETON CONTROLS NADPH OXIDASE ACTIVATION AND G PROTEIN RECRUITMENT MEDIATED BY NEUTROPHIL Gαq-COUPLED RECEPTORS Article Snippet: The P2Y 2 R antagonist AR-C118925 ((5-[[5-(2,8-dimethyl-5Hdibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]-N-2H-tetrazol-5-yl-2-furan-carboxamide)) and the Article Title: Activation and signaling characteristics of the hydroxy-carboxylic acid 3 receptor identified in human neutrophils through a microfluidic flow cell technique. Article Snippet: The Article Title: LTB 4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT 1 receptor activates the free fatty acid receptor 2. Article Snippet: The Gαq inhibitor YM-254890 (#257-00631) was purchased from FUJIFILM Wako Chemicals Europe (Nordic Biolabs, Täby, Sweden) and the FFA2R antagonist CATPB ((S)-3-(2-(3-Chlorophenyl)acetamido)-4-(4-(trifluoromethyl) phenyl) butanoic acid); #5903) was from Tocris Bioscience (Bristol, UK). Control:Article Title: The ketone body acetoacetate activates human neutrophils through FFA2R Article Snippet: The Article Title: Disruption of the actin cytoskeleton with latrunculin A controls ATP-induced NADPH oxidase activity and the recruitment of G proteins by neutrophil Gα q -coupled receptors. Article Snippet: The P2Y2R antagonist AR-C118925 ((5-[[5-(2,8-dimethyl-5Hdibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]N-2H-tetrazol-5-yl-2-furan-carboxamide)) and the Article Title: THE ACTIN CYTOSKELETON CONTROLS NADPH OXIDASE ACTIVATION AND G PROTEIN RECRUITMENT MEDIATED BY NEUTROPHIL Gαq-COUPLED RECEPTORS Article Snippet: The P2Y 2 R antagonist AR-C118925 ((5-[[5-(2,8-dimethyl-5Hdibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]-N-2H-tetrazol-5-yl-2-furan-carboxamide)) and the Article Title: Activation and signaling characteristics of the hydroxy-carboxylic acid 3 receptor identified in human neutrophils through a microfluidic flow cell technique. Article Snippet: The Article Title: LTB 4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT 1 receptor activates the free fatty acid receptor 2. Article Snippet: The Gαq inhibitor YM-254890 (#257-00631) was purchased from FUJIFILM Wako Chemicals Europe (Nordic Biolabs, Täby, Sweden) and the FFA2R antagonist CATPB ((S)-3-(2-(3-Chlorophenyl)acetamido)-4-(4-(trifluoromethyl) phenyl) butanoic acid); #5903) was from Tocris Bioscience (Bristol, UK). Produced:Article Title: The ketone body acetoacetate activates human neutrophils through FFA2R Article Snippet: The Article Title: Disruption of the actin cytoskeleton with latrunculin A controls ATP-induced NADPH oxidase activity and the recruitment of G proteins by neutrophil Gα q -coupled receptors. Article Snippet: The P2Y2R antagonist AR-C118925 ((5-[[5-(2,8-dimethyl-5Hdibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]N-2H-tetrazol-5-yl-2-furan-carboxamide)) and the Article Title: THE ACTIN CYTOSKELETON CONTROLS NADPH OXIDASE ACTIVATION AND G PROTEIN RECRUITMENT MEDIATED BY NEUTROPHIL Gαq-COUPLED RECEPTORS Article Snippet: The P2Y 2 R antagonist AR-C118925 ((5-[[5-(2,8-dimethyl-5Hdibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]-N-2H-tetrazol-5-yl-2-furan-carboxamide)) and the Article Title: Activation and signaling characteristics of the hydroxy-carboxylic acid 3 receptor identified in human neutrophils through a microfluidic flow cell technique. Article Snippet: The Article Title: LTB 4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT 1 receptor activates the free fatty acid receptor 2. Article Snippet: The Gαq inhibitor YM-254890 (#257-00631) was purchased from FUJIFILM Wako Chemicals Europe (Nordic Biolabs, Täby, Sweden) and the FFA2R antagonist CATPB ((S)-3-(2-(3-Chlorophenyl)acetamido)-4-(4-(trifluoromethyl) phenyl) butanoic acid); #5903) was from Tocris Bioscience (Bristol, UK). Concentration Assay:Article Title: The ketone body acetoacetate activates human neutrophils through FFA2R Article Snippet: The Article Title: Disruption of the actin cytoskeleton with latrunculin A controls ATP-induced NADPH oxidase activity and the recruitment of G proteins by neutrophil Gα q -coupled receptors. Article Snippet: The P2Y2R antagonist AR-C118925 ((5-[[5-(2,8-dimethyl-5Hdibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]N-2H-tetrazol-5-yl-2-furan-carboxamide)) and the Article Title: THE ACTIN CYTOSKELETON CONTROLS NADPH OXIDASE ACTIVATION AND G PROTEIN RECRUITMENT MEDIATED BY NEUTROPHIL Gαq-COUPLED RECEPTORS Article Snippet: The P2Y 2 R antagonist AR-C118925 ((5-[[5-(2,8-dimethyl-5Hdibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]-N-2H-tetrazol-5-yl-2-furan-carboxamide)) and the Article Title: Activation and signaling characteristics of the hydroxy-carboxylic acid 3 receptor identified in human neutrophils through a microfluidic flow cell technique. Article Snippet: The Article Title: LTB 4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT 1 receptor activates the free fatty acid receptor 2. Article Snippet: The Gαq inhibitor YM-254890 (#257-00631) was purchased from FUJIFILM Wako Chemicals Europe (Nordic Biolabs, Täby, Sweden) and the FFA2R antagonist CATPB ((S)-3-(2-(3-Chlorophenyl)acetamido)-4-(4-(trifluoromethyl) phenyl) butanoic acid); #5903) was from Tocris Bioscience (Bristol, UK). Activity Assay:Article Title: The ketone body acetoacetate activates human neutrophils through FFA2R Article Snippet: The Article Title: Disruption of the actin cytoskeleton with latrunculin A controls ATP-induced NADPH oxidase activity and the recruitment of G proteins by neutrophil Gα q -coupled receptors. Article Snippet: The P2Y2R antagonist AR-C118925 ((5-[[5-(2,8-dimethyl-5Hdibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]N-2H-tetrazol-5-yl-2-furan-carboxamide)) and the Article Title: THE ACTIN CYTOSKELETON CONTROLS NADPH OXIDASE ACTIVATION AND G PROTEIN RECRUITMENT MEDIATED BY NEUTROPHIL Gαq-COUPLED RECEPTORS Article Snippet: The P2Y 2 R antagonist AR-C118925 ((5-[[5-(2,8-dimethyl-5Hdibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]-N-2H-tetrazol-5-yl-2-furan-carboxamide)) and the Article Title: Activation and signaling characteristics of the hydroxy-carboxylic acid 3 receptor identified in human neutrophils through a microfluidic flow cell technique. Article Snippet: The Article Title: LTB 4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT 1 receptor activates the free fatty acid receptor 2. Article Snippet: The Gαq inhibitor YM-254890 (#257-00631) was purchased from FUJIFILM Wako Chemicals Europe (Nordic Biolabs, Täby, Sweden) and the FFA2R antagonist CATPB ((S)-3-(2-(3-Chlorophenyl)acetamido)-4-(4-(trifluoromethyl) phenyl) butanoic acid); #5903) was from Tocris Bioscience (Bristol, UK). Transduction:Article Title: The ketone body acetoacetate activates human neutrophils through FFA2R Article Snippet: The Article Title: Disruption of the actin cytoskeleton with latrunculin A controls ATP-induced NADPH oxidase activity and the recruitment of G proteins by neutrophil Gα q -coupled receptors. Article Snippet: The P2Y2R antagonist AR-C118925 ((5-[[5-(2,8-dimethyl-5Hdibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]N-2H-tetrazol-5-yl-2-furan-carboxamide)) and the Article Title: THE ACTIN CYTOSKELETON CONTROLS NADPH OXIDASE ACTIVATION AND G PROTEIN RECRUITMENT MEDIATED BY NEUTROPHIL Gαq-COUPLED RECEPTORS Article Snippet: The P2Y 2 R antagonist AR-C118925 ((5-[[5-(2,8-dimethyl-5Hdibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]-N-2H-tetrazol-5-yl-2-furan-carboxamide)) and the Article Title: Activation and signaling characteristics of the hydroxy-carboxylic acid 3 receptor identified in human neutrophils through a microfluidic flow cell technique. Article Snippet: The Article Title: LTB 4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT 1 receptor activates the free fatty acid receptor 2. Article Snippet: The Gαq inhibitor YM-254890 (#257-00631) was purchased from FUJIFILM Wako Chemicals Europe (Nordic Biolabs, Täby, Sweden) and the FFA2R antagonist CATPB ((S)-3-(2-(3-Chlorophenyl)acetamido)-4-(4-(trifluoromethyl) phenyl) butanoic acid); #5903) was from Tocris Bioscience (Bristol, UK). Translocation Assay:Article Title: The ketone body acetoacetate activates human neutrophils through FFA2R Article Snippet: The Article Title: Disruption of the actin cytoskeleton with latrunculin A controls ATP-induced NADPH oxidase activity and the recruitment of G proteins by neutrophil Gα q -coupled receptors. Article Snippet: The P2Y2R antagonist AR-C118925 ((5-[[5-(2,8-dimethyl-5Hdibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]N-2H-tetrazol-5-yl-2-furan-carboxamide)) and the Article Title: THE ACTIN CYTOSKELETON CONTROLS NADPH OXIDASE ACTIVATION AND G PROTEIN RECRUITMENT MEDIATED BY NEUTROPHIL Gαq-COUPLED RECEPTORS Article Snippet: The P2Y 2 R antagonist AR-C118925 ((5-[[5-(2,8-dimethyl-5Hdibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]-N-2H-tetrazol-5-yl-2-furan-carboxamide)) and the Article Title: Activation and signaling characteristics of the hydroxy-carboxylic acid 3 receptor identified in human neutrophils through a microfluidic flow cell technique. Article Snippet: The Article Title: LTB 4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT 1 receptor activates the free fatty acid receptor 2. Article Snippet: The Gαq inhibitor YM-254890 (#257-00631) was purchased from FUJIFILM Wako Chemicals Europe (Nordic Biolabs, Täby, Sweden) and the FFA2R antagonist CATPB ((S)-3-(2-(3-Chlorophenyl)acetamido)-4-(4-(trifluoromethyl) phenyl) butanoic acid); #5903) was from Tocris Bioscience (Bristol, UK). Fluorescence:Article Title: The ketone body acetoacetate activates human neutrophils through FFA2R Article Snippet: The Article Title: Disruption of the actin cytoskeleton with latrunculin A controls ATP-induced NADPH oxidase activity and the recruitment of G proteins by neutrophil Gα q -coupled receptors. Article Snippet: The P2Y2R antagonist AR-C118925 ((5-[[5-(2,8-dimethyl-5Hdibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]N-2H-tetrazol-5-yl-2-furan-carboxamide)) and the Article Title: THE ACTIN CYTOSKELETON CONTROLS NADPH OXIDASE ACTIVATION AND G PROTEIN RECRUITMENT MEDIATED BY NEUTROPHIL Gαq-COUPLED RECEPTORS Article Snippet: The P2Y 2 R antagonist AR-C118925 ((5-[[5-(2,8-dimethyl-5Hdibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]-N-2H-tetrazol-5-yl-2-furan-carboxamide)) and the Article Title: Activation and signaling characteristics of the hydroxy-carboxylic acid 3 receptor identified in human neutrophils through a microfluidic flow cell technique. Article Snippet: The Article Title: LTB 4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT 1 receptor activates the free fatty acid receptor 2. Article Snippet: The Gαq inhibitor YM-254890 (#257-00631) was purchased from FUJIFILM Wako Chemicals Europe (Nordic Biolabs, Täby, Sweden) and the FFA2R antagonist CATPB ((S)-3-(2-(3-Chlorophenyl)acetamido)-4-(4-(trifluoromethyl) phenyl) butanoic acid); #5903) was from Tocris Bioscience (Bristol, UK). |